Compagnie Lombard Odier SCmA’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.59M | Hold |
12,565
| – | – | 0.07% | 96 |
|
2025
Q1 | $6.09M | Buy |
12,565
+3,000
| +31% | +$1.45M | 0.07% | 102 |
|
2024
Q4 | $3.85M | Sell |
9,565
-864
| -8% | -$348K | 0.06% | 103 |
|
2024
Q3 | $4.85M | Buy |
10,429
+3,200
| +44% | +$1.49M | 0.08% | 97 |
|
2024
Q2 | $3.39M | Buy |
7,229
+2,929
| +68% | +$1.37M | 0.06% | 107 |
|
2024
Q1 | $1.8M | Buy |
4,300
+3,000
| +231% | +$1.25M | 0.03% | 137 |
|
2023
Q4 | $529K | Hold |
1,300
| – | – | 0.01% | 216 |
|
2023
Q3 | $452K | Sell |
1,300
-600
| -32% | -$209K | 0.01% | 194 |
|
2023
Q2 | $669K | Hold |
1,900
| – | – | 0.02% | 158 |
|
2023
Q1 | $599K | Sell |
1,900
-3,614
| -66% | -$1.14M | 0.02% | 186 |
|
2022
Q4 | $1.59M | Buy |
5,514
+4,214
| +324% | +$1.22M | 0.04% | 139 |
|
2022
Q3 | $376K | Sell |
1,300
-330
| -20% | -$95.4K | 0.01% | 237 |
|
2022
Q2 | $460K | Hold |
1,630
| – | – | 0.01% | 209 |
|
2022
Q1 | $425K | Hold |
1,630
| – | – | 0.01% | 229 |
|
2021
Q4 | $358K | Buy |
1,630
+1,250
| +329% | +$275K | 0.01% | 283 |
|
2021
Q3 | $69K | Hold |
380
| – | – | ﹤0.01% | 466 |
|
2021
Q2 | $76K | Buy |
380
+130
| +52% | +$26K | ﹤0.01% | 440 |
|
2021
Q1 | $54K | Buy |
+250
| New | +$54K | ﹤0.01% | 497 |
|
2020
Q3 | – | Sell |
-325
| Closed | -$94K | – | 581 |
|
2020
Q2 | $94K | Buy |
325
+75
| +30% | +$21.7K | ﹤0.01% | 322 |
|
2020
Q1 | $59K | Buy |
+250
| New | +$59K | ﹤0.01% | 339 |
|
2019
Q1 | – | Sell |
-300
| Closed | -$50K | – | 596 |
|
2018
Q4 | $50K | Sell |
300
-200
| -40% | -$33.3K | ﹤0.01% | 383 |
|
2018
Q3 | $96K | Hold |
500
| – | – | ﹤0.01% | 352 |
|
2018
Q2 | $85K | Buy |
+500
| New | +$85K | ﹤0.01% | 374 |
|
2015
Q2 | – | Sell |
-537
| Closed | -$63K | – | 939 |
|
2015
Q1 | $63K | Buy |
+537
| New | +$63K | ﹤0.01% | 760 |
|
2014
Q4 | – | Sell |
-1,818
| Closed | -$204K | – | 863 |
|
2014
Q3 | $204K | Sell |
1,818
-4,371
| -71% | -$490K | 0.01% | 501 |
|
2014
Q2 | $586K | Buy |
6,189
+2,506
| +68% | +$237K | 0.02% | 288 |
|
2014
Q1 | $261K | Buy |
3,683
+1,357
| +58% | +$96.2K | 0.01% | 452 |
|
2013
Q4 | $173K | Buy |
+2,326
| New | +$173K | 0.01% | 559 |
|